Chitosan Nanovaccines as Efficient Carrier Adjuvant System for IL-12 with Enhanced Protection Against HBV
Huajun Zhao,1 Haigang Wang,1 Yifei Hu,1 Dongqing Xu,1 Chunlai Yin,2 Qiuju Han,1 Jian Zhang1 1Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan, People’s Republic of China; 2Department of Immunology, Dalian Medical University, Dalian,...
Guardado en:
Autores principales: | Zhao H, Wang H, Hu Y, Xu D, Yin C, Han Q, Zhang J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1601050849484b23979b8c5495c34268 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen W, et al.
Publicado: (2021) -
Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2
por: Ding P, et al.
Publicado: (2019) -
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
por: Ting Cai, et al.
Publicado: (2021) -
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
por: Dong Y, et al.
Publicado: (2020) -
Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8+ T Cell Memory and Delayed Tumor Progression
por: Darling R, et al.
Publicado: (2020)